Lack of an Additive Effect between the Deletions of Klf5 and Nkx3-1 in Mouse Prostatic Tumorigenesis

Journal of Genetics and Genomics

Volumn 40, Issue 6, 2013, Pages 315-318

  Xing, Changsheng ^a,b   Fu, Xiaoying ^b,c   Sun, Xiaodong ^b   Dong, Jin Tang ^a,b  

^a NANKAI UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX3.1; UNCLASSIFIED DRUG;

ALLELE; ANIMAL TISSUE; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; DYSPLASIA; EPITHELIUM HYPERPLASIA; GENE DELETION; GENE INACTIVATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LETTER; MOUSE; NONHUMAN; PROSTATE CANCER; PROSTATE CARCINOGENESIS; PROTEIN EXPRESSION;

ANIMALS; CARCINOGENESIS; FEMALE; GENE DELETION; HOMEODOMAIN PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; MICE, KNOCKOUT; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84879413352     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2013.04.005     Document Type: Letter

References (20)

1. Abate-Shen C., Banach-Petrosky W.A., Sun X., Economides K.D., Desai N., Gregg J.P., Borowsky A.D., Cardiff R.D., Shen M.M. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res. 2003, 63:3886-3890.
2. Abdulkadir S.A., Magee J.A., Peters T.J., Kaleem Z., Naughton C.K., Humphrey P.A., Milbrandt J. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol. Cell. Biol. 2002, 22:1495-1503.
3. Anderson P.D., McKissic S.A., Logan M., Roh M., Franco O.E., Wang J., Doubinskaia I., Meer R., Hayward S.W., Eischen C.M., Eltoum I.E., Abdulkadir S.A. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. J. Clin. Invest. 2012, 122:1907-1919.
4. Bhatia-Gaur R., Donjacour A.A., Sciavolino P.J., Kim M., Desai N., Young P., Norton C.R., Gridley T., Cardiff R.D., Cunha G.R., Abate-Shen C., Shen M.M. Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 1999, 13:966-977.
5. Chen C., Bhalala H.V., Vessella R.L., Dong J.T. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate 2003, 55:81-88.
6. Chen C., Brabham W.W., Stultz B.G., Frierson H.F., Barrett J.C., Sawyers C.L., Isaacs J.T., Dong J.T. Defining a common region of deletion at 13q21 in human cancers. Genes Chromosomes Cancer 2001, 31:333-344.
7. Dong J.T. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev. 2001, 20:173-193.
8. Dong J.T., Chen C., Stultz B.G., Isaacs J.T., Frierson H.F. Deletion at 13q21 is associated with aggressive prostate cancers. Cancer Res. 2000, 60:3880-3883.
9. Guo P., Dong X.Y., Zhao K.W., Sun X., Li Q., Dong J.T. Opposing effects of KLF5 on the transcription of MYC in epithelial proliferation in the context of transforming growth factor β. J. Biol. Chem. 2009, 284:28243-28252.
10. He W.W., Sciavolino P.J., Wing J., Augustus M., Hudson P., Meissner P.S., Curtis R.T., Shell B.K., Bostwick D.G., Tindall D.J., Gelmann E.P., Abate-Shen C., Carter K.C. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics 1997, 43:69-77.
11. Iwata T., Schultz D., Hicks J., Hubbard G.K., Mutton L.N., Lotan T.L., Bethel C., Lotz M.T., Yegnasubramanian S., Nelson W.G., Dang C.V., Xu M., Anele U., Koh C.M., Bieberich C.J., De Marzo A.M. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells. PLoS ONE 2010, 5. e9427.
12. Knuutila S., Bjorkqvist A.M., Autio K., Tarkkanen M., Wolf M., Monni O., Szymanska J., Larramendy M.L., Tapper J., Pere H., El-Rifai W., Hemmer S., Wasenius V.M., Vidgren V., Zhu Y. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am. J. Pathol. 1998, 152:1107-1123.
13. Knuutila S., Aalto Y., Autio K., Bjorkqvist A.M., El-Rifai W., Hemmer S., Huhta T., Kettunen E., Kiuru-Kuhlefelt S., Larramendy M.L., Lushnikova T., Monni O., Pere H., Tapper J., Tarkkanen M., Varis A., Wasenius V.M., Wolf M., Zhu Y. DNA copy number losses in human neoplasms. Am. J. Pathol. 1999, 155:683-694.
14. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947.
15. Nakajima Y., Akaogi K., Suzuki T., Osakabe A., Yamaguchi C., Sunahara N., Ishida J., Kako K., Ogawa S., Fujimura T., Homma Y., Fukamizu A., Murayama A., Kimura K., Inoue S., Yanagisawa J. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5. Sci. Signal. 2011, 4. ra22.
16. Pan Y., Lui W.O., Nupponen N., Larsson C., Ji Visakorpi T., Bergerheim U.S., Kytola S. 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines. Genes Chromosomes Cancer 2001, 30:187-195.
17. Shappell S.B., Thomas G.V., Roberts R.L., Herbert R., Ittmann M.M., Rubin M.A., Humphrey P.A., Sundberg J.P., Rozengurt N., Barrios R., Ward J.M., Cardiff R.D. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res. 2004, 64:2270-2305.
18. Sun X., Frierson H.F., Chen C., Li C., Ran Q., Otto K.B., Cantarel B.L., Vessella R.L., Gao A.C., Petros J., Miura Y., Simons J.W., Dong J.T. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat. Genet. 2005, 37:407-412.
19. Valkenburg K.C., Williams B.O. Mouse models of prostate cancer. Prostate Cancer 2011, 2011:895238.
20. Wang S., Gao J., Lei Q., Rozengurt N., Pritchard C., Jiao J., Thomas G.V., Li G., Roy-Burman P., Nelson P.S., Liu X., Wu H. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 2003, 4:209-221.